Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPABLE: Caduet in African Americans with Hypertension and Dyslipidemia
NCT00150384Phase 4Completed
- Sponsor
- Viatris
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amlodipine in hypertension (HTN), dyslipidemia, sponsored by Viatris. Started Jul 2004; status: completed.
02
Drugs
amlodipine
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT00150384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150384.